For the quarter ending 2026-03-31, RVRC had -$758K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 |
|---|---|---|
| Net loss | - | -13,449 |
| Depreciation | - | 6 |
| Stock based compensation | - | 624 |
| Change in deferred tax liability, net | - | 358 |
| Intangible asset and goodwill impairment expenses | - | 9,684 |
| Reduction in the carrying amount of operating lease right of use asset | - | 7 |
| Finance expense (income) | - | -3 |
| Net loss | -725 | - |
| Operating lease liability | - | -7 |
| Depreciation | 2 | - |
| Other current assets | - | 137 |
| Finance income | -14 | - |
| Other account payables | - | 359 |
| Other current assets | -34 | - |
| Accounts payable | - | 21 |
| Other account payables | 66 | - |
| Net cash used in operating activities | - | -2,531 |
| Accounts payable | 68 | - |
| Deposit for operating right of use assets | - | 18 |
| Net cash used in operating activities | -541 | - |
| Withdrawal from (investment in) short term deposit | - | -975 |
| Withdrawal from short term deposit | 200 | - |
| Investment in restricted deposit | - | 9 |
| Deposit for operating right of use assets | 18 | - |
| Purchase of property, plant and equipment | -1 | 7 |
| Net cash provided by investing activities | -217 | 941 |
| Increase (decrease) in cash and cash equivalents | -758 | -1,590 |
| Cash and cash equivalents at the beginning of period | 1,678 | 3,268 |
| Cash and cash equivalents at the end of period | 920 | 1,678 |
Revium Rx. (RVRC)
Revium Rx. (RVRC)